Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program.
Matthews DR, Li Q, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Desai M, Hiatt WR, Nehler M, Fabbrini E, Kavalam M, Lee M, Neal B.
Matthews DR, et al. Among authors: lee m.
Diabetologia. 2019 Jun;62(6):926-938. doi: 10.1007/s00125-019-4839-8. Epub 2019 Mar 12.
Diabetologia. 2019.
PMID: 30868176
Free PMC article.
Clinical Trial.